Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study
Observational analysis shows 5-year overall survival at 90.9% in locally advanced rectal cancer patients, indicating effectiveness of neoadjuvant chemoradiotherapy.
Key Points
Overall survival reached 90.9% at 5 years, revealing strong long-term outcomes for patients with locally advanced rectal cancer.
Patients experienced local recurrence rates of 3.6% and systemic recurrence rates of 7.9%.
Observational analysis assessing 277 patients with pathological complete response after neoadjuvant chemoradiotherapy.
Results suggest that neoadjuvant chemoradiotherapy is effective for improving oncological outcomes in rectal cancer.